| UniProt ID | SHLB1_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y371 | |
| Protein Name | Endophilin-B1 | |
| Gene Name | SH3GLB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 365 | |
| Subcellular Localization |
Cytoplasm . Golgi apparatus membrane Peripheral membrane protein. Mitochondrion outer membrane Peripheral membrane protein . Cytoplasmic vesicle, autophagosome membrane . Midbody . Association with the Golgi apparatus depends on the cell type (By |
|
| Protein Description | May be required for normal outer mitochondrial membrane dynamics. [PubMed: 15452144 Required for coatomer-mediated retrograde transport in certain cells (By similarity May recruit other proteins to membranes with high curvature. May promote membrane fusion] | |
| Protein Sequence | MNIMDFNVKKLAADAGTFLSRAVQFTEEKLGQAEKTELDAHLENLLSKAECTKIWTEKIMKQTEVLLQPNPNARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIKCGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITRLLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSDLKECSGSRKARVLYDYDAANSTELSLLADEVITVFSVVGMDSDWLMGERGNQKGKVPITYLELLN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MNIMDFNV -------CCCCCCCH | 7.47 | 22814378 | |
| 9 (in isoform 2) | Ubiquitination | - | 43.08 | - | |
| 9 | Ubiquitination | NIMDFNVKKLAADAG CCCCCCHHHHHHHHH | 43.08 | - | |
| 10 | Ubiquitination | IMDFNVKKLAADAGT CCCCCHHHHHHHHHH | 38.79 | - | |
| 10 (in isoform 2) | Ubiquitination | - | 38.79 | - | |
| 17 | Phosphorylation | KLAADAGTFLSRAVQ HHHHHHHHHHHHHHH | 24.11 | 28555341 | |
| 20 | Phosphorylation | ADAGTFLSRAVQFTE HHHHHHHHHHHHHHH | 17.63 | 28555341 | |
| 26 | Phosphorylation | LSRAVQFTEEKLGQA HHHHHHHHHHHHCHH | 26.58 | 22210691 | |
| 29 (in isoform 2) | Ubiquitination | - | 52.24 | - | |
| 29 | Ubiquitination | AVQFTEEKLGQAEKT HHHHHHHHHCHHHHH | 52.24 | - | |
| 35 (in isoform 2) | Ubiquitination | - | 50.76 | - | |
| 35 | Ubiquitination | EKLGQAEKTELDAHL HHHCHHHHHHHHHHH | 50.76 | - | |
| 48 (in isoform 2) | Ubiquitination | - | 48.45 | - | |
| 48 | Acetylation | HLENLLSKAECTKIW HHHHHHHHHHHHHHH | 48.45 | 26051181 | |
| 48 | Ubiquitination | HLENLLSKAECTKIW HHHHHHHHHHHHHHH | 48.45 | - | |
| 53 | Ubiquitination | LSKAECTKIWTEKIM HHHHHHHHHHHHHHH | 48.15 | - | |
| 53 (in isoform 2) | Ubiquitination | - | 48.15 | - | |
| 58 (in isoform 2) | Ubiquitination | - | 40.50 | - | |
| 58 | Ubiquitination | CTKIWTEKIMKQTEV HHHHHHHHHHHHHCH | 40.50 | - | |
| 61 | Ubiquitination | IWTEKIMKQTEVLLQ HHHHHHHHHHCHHCC | 58.50 | - | |
| 61 (in isoform 2) | Ubiquitination | - | 58.50 | - | |
| 80 | Phosphorylation | ARIEEFVYEKLDRKA CCHHHHHHHHCCCCC | 16.80 | 25159151 | |
| 80 (in isoform 2) | Phosphorylation | - | 16.80 | 25147952 | |
| 82 (in isoform 2) | Ubiquitination | - | 37.69 | 21906983 | |
| 82 (in isoform 1) | Ubiquitination | - | 37.69 | 21906983 | |
| 82 | Ubiquitination | IEEFVYEKLDRKAPS HHHHHHHHCCCCCCC | 37.69 | 2190698 | |
| 89 | Phosphorylation | KLDRKAPSRINNPEL HCCCCCCCCCCCHHH | 51.13 | 26552605 | |
| 100 | Phosphorylation | NPELLGQYMIDAGTE CHHHHHHHEECCCCC | 8.34 | 26552605 | |
| 106 | Phosphorylation | QYMIDAGTEFGPGTA HHEECCCCCCCCCCH | 29.84 | 26552605 | |
| 112 | Phosphorylation | GTEFGPGTAYGNALI CCCCCCCCHHHCEEE | 21.60 | 26552605 | |
| 114 | Phosphorylation | EFGPGTAYGNALIKC CCCCCCHHHCEEEEC | 15.68 | 26552605 | |
| 124 | Phosphorylation | ALIKCGETQKRIGTA EEEECCCHHHCCCCC | 25.36 | 26552605 | |
| 138 | Phosphorylation | ADRELIQTSALNFLT CCHHHHHHHHHHHHH | 14.69 | 20068231 | |
| 139 | Phosphorylation | DRELIQTSALNFLTP CHHHHHHHHHHHHHH | 17.87 | 20068231 | |
| 145 | Phosphorylation | TSALNFLTPLRNFIE HHHHHHHHHHHHHHH | 19.01 | 20068231 | |
| 155 | Phosphorylation | RNFIEGDYKTIAKER HHHHHCCHHHHHHHH | 22.38 | 28060719 | |
| 156 | Sumoylation | NFIEGDYKTIAKERK HHHHCCHHHHHHHHH | 37.89 | - | |
| 156 | Sumoylation | NFIEGDYKTIAKERK HHHHCCHHHHHHHHH | 37.89 | - | |
| 156 | Ubiquitination | NFIEGDYKTIAKERK HHHHCCHHHHHHHHH | 37.89 | - | |
| 156 (in isoform 2) | Ubiquitination | - | 37.89 | - | |
| 157 | Phosphorylation | FIEGDYKTIAKERKL HHHCCHHHHHHHHHH | 21.67 | 28060719 | |
| 176 (in isoform 2) | Ubiquitination | - | 35.58 | - | |
| 176 | Ubiquitination | RLDLDAAKTRLKKAK CCCHHHHHHHHHHHH | 35.58 | - | |
| 187 | Phosphorylation | KKAKAAETRNSSEQE HHHHHHHHCCCHHHH | 30.35 | 28102081 | |
| 190 | Phosphorylation | KAAETRNSSEQELRI HHHHHCCCHHHHHHH | 31.77 | 26462736 | |
| 191 | Phosphorylation | AAETRNSSEQELRIT HHHHCCCHHHHHHHH | 47.01 | 30622161 | |
| 236 | Phosphorylation | DFVEAQMTYYAQCYQ HHHHHHHHHHHHHHH | 10.99 | 24043423 | |
| 237 | Phosphorylation | FVEAQMTYYAQCYQY HHHHHHHHHHHHHHH | 7.46 | 24043423 | |
| 238 | Phosphorylation | VEAQMTYYAQCYQYM HHHHHHHHHHHHHHH | 4.88 | 24043423 | |
| 242 | Phosphorylation | MTYYAQCYQYMLDLQ HHHHHHHHHHHHHHH | 7.21 | 24043423 | |
| 244 | Phosphorylation | YYAQCYQYMLDLQKQ HHHHHHHHHHHHHHH | 3.52 | 24043423 | |
| 254 | Phosphorylation | DLQKQLGSFPSNYLS HHHHHHCCCCHHHHC | 42.44 | 20068231 | |
| 257 | Phosphorylation | KQLGSFPSNYLSNNN HHHCCCCHHHHCCCC | 35.78 | 20068231 | |
| 259 | Phosphorylation | LGSFPSNYLSNNNQT HCCCCHHHHCCCCCC | 18.82 | 20068231 | |
| 261 | Phosphorylation | SFPSNYLSNNNQTSV CCCHHHHCCCCCCCC | 27.44 | 20068231 | |
| 266 | Phosphorylation | YLSNNNQTSVTPVPS HHCCCCCCCCCCCCC | 27.56 | 20068231 | |
| 267 | Phosphorylation | LSNNNQTSVTPVPSV HCCCCCCCCCCCCCC | 17.77 | 20068231 | |
| 269 | Phosphorylation | NNNQTSVTPVPSVLP CCCCCCCCCCCCCCC | 20.52 | 20068231 | |
| 273 | Phosphorylation | TSVTPVPSVLPNAIG CCCCCCCCCCCCCCC | 36.20 | 20068231 | |
| 281 | Phosphorylation | VLPNAIGSSAMASTS CCCCCCCCCCCCCCC | 14.60 | 20068231 | |
| 282 | Phosphorylation | LPNAIGSSAMASTSG CCCCCCCCCCCCCCC | 19.49 | 20068231 | |
| 286 | Phosphorylation | IGSSAMASTSGLVIT CCCCCCCCCCCEEEE | 15.26 | 20068231 | |
| 287 | Phosphorylation | GSSAMASTSGLVITS CCCCCCCCCCEEEEC | 19.78 | 20068231 | |
| 288 | Phosphorylation | SSAMASTSGLVITSP CCCCCCCCCEEEECC | 27.86 | 20068231 | |
| 293 | Phosphorylation | STSGLVITSPSNLSD CCCCEEEECCCCHHH | 27.40 | 20068231 | |
| 294 | Phosphorylation | TSGLVITSPSNLSDL CCCEEEECCCCHHHH | 18.40 | 20068231 | |
| 296 | Phosphorylation | GLVITSPSNLSDLKE CEEEECCCCHHHHHH | 50.61 | 20068231 | |
| 299 | Phosphorylation | ITSPSNLSDLKECSG EECCCCHHHHHHCCC | 45.18 | 20068231 | |
| 307 | Phosphorylation | DLKECSGSRKARVLY HHHHCCCCCCEEEEE | 17.83 | 28258704 | |
| 314 | Phosphorylation | SRKARVLYDYDAANS CCCEEEEECCCCCCC | 15.03 | 20068231 | |
| 316 | Phosphorylation | KARVLYDYDAANSTE CEEEEECCCCCCCHH | 8.23 | 20068231 | |
| 321 | Phosphorylation | YDYDAANSTELSLLA ECCCCCCCHHHHHHH | 20.66 | 20068231 | |
| 322 | Phosphorylation | DYDAANSTELSLLAD CCCCCCCHHHHHHHC | 40.53 | 20068231 | |
| 325 | Phosphorylation | AANSTELSLLADEVI CCCCHHHHHHHCCEE | 18.33 | 20068231 | |
| 333 | Phosphorylation | LLADEVITVFSVVGM HHHCCEEEHEEEECC | 22.22 | 20068231 | |
| 336 | Phosphorylation | DEVITVFSVVGMDSD CCEEEHEEEECCCCH | 16.14 | 20068231 | |
| 342 | Phosphorylation | FSVVGMDSDWLMGER EEEECCCCHHHCCCC | 23.07 | 20068231 | |
| 355 | Sumoylation | ERGNQKGKVPITYLE CCCCCCCCCEEEEEE | 52.45 | - | |
| 355 | Ubiquitination | ERGNQKGKVPITYLE CCCCCCCCCEEEEEE | 52.45 | - | |
| 376 (in isoform 2) | Ubiquitination | - | - |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 145 | T | Phosphorylation |
| 21499257 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHLB1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Cdk5-mediated phosphorylation of endophilin B1 is required forinduced autophagy in models of Parkinson's disease."; Wong A.S., Lee R.H., Cheung A.Y., Yeung P.K., Chung S.K., Cheung Z.H.,Ip N.Y.; Nat. Cell Biol. 13:568-579(2011). Cited for: PHOSPHORYLATION AT THR-145, AND MUTAGENESIS OF THR-145. | |